注射用抑菌水市场：按容器类型、按应用、按最终用户、按地区

预计2024年全球抑菌注射水市场规模为12.2亿美元，预计2031年将达20.9亿美元，2024年至2031年复合年增长率为8%。

图：2024 年按地区分類的抑菌注射水市场占有率（%）

抑菌注射用水是指在配製和使用过程中含有适当浓度的防腐剂以抑制接种微生物生长的无菌水。抑菌水用于冲调粉状药物和其他製剂，以消除注射和输注过程中微生物污染的风险。在医院和诊所，它被用来配製抗生素、抗真菌药物和其他注射药物等药物。全球慢性病和感染疾病的流行以及医疗保健支出的增加可能会推动预测期内对注射用抑菌水的需求。

市场动态：

癌症和心血管疾病等慢性疾病的盛行率不断上升，可能会增加对各种治疗注射剂的需求，这将推动预测期内全球抑菌注射水市场的成长。医疗保健支出的增加，尤其是在新兴国家，以及医疗设施的改善，可以成为市场成长的动力。然而，生理食盐水等替代品的可用性可能会阻碍市场成长。同时，正在研究开发更有效的防腐剂和与更广泛的注射药物相容的配方，这可能在不久的将来为製造商带来利润丰厚的机会。

本研究的主要特点

该报告对全球抑菌注射用水市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。发表。

它揭示了各个细分市场的潜在商机，并解释了该市场中有吸引力的投资提案的矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。

本研究涵盖的主要企业包括 B. Braun Medical Inc、HOSPIRA、Medline、Baxter、ICU Medical 和 Hyperdrug。

本报告中的见解将帮助负责人和公司经营团队就未来的产品发布、升级、市场扩张和行销策略做出明智的决策。

全球注射用抑菌水市场报告迎合了该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。

相关人员可以透过用于分析全球注射用抑菌水市场的各种策略矩阵来促进他们的决策。

目录

第一章 研究目的与前提

• 研究目的
• 先决条件
• 简称

第二章 市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要

第三章 市场动态、法规与趋势分析

• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 影响分析
• 市场趋势
• 主要进展
• 监管场景
• 收购和合作场景
• 资金筹措和投资
• PEST分析
• 波特的分析

第四章全球注射抑菌水市场－冠状病毒（COVID-19）大流行的影响

• 整体影响
• 政府倡议
• COVID-19 对市场的影响

第五章2019-2031年全球注射抑菌水市场（依容器型态）

• 单剂量管瓶
• 多剂量管瓶

第六章全球注射抑菌水市场（依应用），2019-2031

• 药品製造
• 医疗用途
• 诊断用途
• 其他的

第 7 章 全球注射抑菌水市场，依最终用户划分，2019-2031 年

• 医院/诊所
• 诊断实验室
• 研究实验室
• 其他的

第八章2019-2031年全球注射抑菌水市场（按地区）

• 北美洲
• 拉丁美洲
• 欧洲
• 亚太地区
• 中东
• 非洲

第9章 竞争格局

• 公司简介
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • B. Braun Melsungen AG
  • Eagle Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz（a Novartis division）
  • Merck &Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

第10章分析师建议

第十一章 参考文献与调查方法

• 参考
• 调查方法

Global bacteriostatic water for injection market is estimated to be valued at USD 1.22 Billion in 2024 and is expected to reach USD 2.09 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 8% from 2024 to 2031.

Figure. Bacteriostatic Water for Injection Market Share (%), By Region, 2024

Bacteriostatic water for injection refers to sterile water that contains a suitable concentration of preservative to inhibit the growth of micro-organisms inoculated during its preparation or intended use. Bacteriostatic water is used in the reconstitution of powdered medications and other preparations to eliminate the risk of microbial contamination during injection or infusion. It is used in hospitals and clinics for reconstituting medications such as antibiotics, antifungal drugs and other injectable drugs. Growing prevalence of chronic and infectious diseases worldwide along with rising healthcare expenditures can boost demand for bacteriostatic water for injection over the forecast period.

Market Dynamics:

Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders can boost demand for various therapeutic injectable drugs, and this is expected to drive the global bacteriostatic water for injection market growth during the forecast period. Rising healthcare expenditures along with improving access to healthcare facilities especially in developing countries can drive the market growth. However, availability of substitute products such as normal saline can hamper the market growth. Meanwhile, ongoing research towards development of more effective preservatives and formulations compatible with wider range of injectable drugs can offer lucrative opportunities for manufacturers in the near future.

Key features of the study:

This report provides in-depth analysis of the global bacteriostatic water for injection market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

Key companies covered as a part of this study include B. Braun Medical Inc, HOSPIRA, Medline, Baxter, ICU Medical and Hyperdrug

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global bacteriostatic water for injection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacteriostatic water for injection market

Detailed Segmentation-

• Container Type Insights (Revenue, USD Bn, 2019 - 2031)
  • Single-Dose Vials
  • Multi-Dose Vials
• Application Insights (Revenue, USD Bn, 2019 - 2031)
  • Pharmaceutical Manufacturing
  • Medical Use
  • Diagnostic Applications
  • Others
• End User Insights (Revenue, USD Bn, 2019 - 2031)
  • Hospital & Clinics
  • Diagnostic Labs
  • Research Labs
  • Others
• Regional Insights (Revenue, USD Bn 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Baxter International Inc.
  • Fresenius Kabi AG
  • Hospira, Inc.
  • Braun Melsungen AG
  • Eagle Pharmaceuticals, Inc.
  • Sagent Pharmaceuticals, Inc.
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Container Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Bacteriostatic Water for Injection Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Bacteriostatic Water for Injection Market, By Container Type, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Single-Dose Vials
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Multi-Dose Vials
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Bacteriostatic Water for Injection Market, By Application, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Pharmaceutical Manufacturing
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Medical Use
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Applications
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Bacteriostatic Water for Injection Market, By End User, 2019 - 2031, (USD Bn)

• Overview
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Hospital & Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Diagnostic Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Research Labs
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Bacteriostatic Water for Injection Market, By Region, 2019 - 2031, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2031
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • Baxter International Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fresenius Kabi AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Hospira, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • B. Braun Melsungen AG
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Eagle Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sagent Pharmaceuticals, Inc.
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter Healthcare Corporation
  • MediPharma
  • AstraZeneca
  • Hikma Pharmaceuticals PLC
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz (a Novartis division)
  • Merck & Co., Inc.
  • GlaxoSmithKline PLC
  • Cipla Limited
  • Sun Pharmaceutical Industries Ltd.
  • Roche Holding AG
  • Alvogen
  • Zydus Cadila

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact